Back to top

BMY Maintained by Guggenheim -- Price Target Raised to $75.00

BMY Maintained by Guggenheim -- Price Target Raised to $75.00

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Bristol Myers Squibb Company (BMY)